News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
487,784 Results
Type
Article (8016)
Company Profile (143)
Press Release (479625)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166739)
Career Advice (304)
Deals (25738)
Drug Delivery (7)
Drug Development (52873)
Employer Resources (14)
FDA (9760)
Job Trends (8572)
News (238192)
Policy (17898)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (8)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (2)
2027 Genetown Premier (1)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (495)
Accelerated approval (29)
ADA (18)
Adcomms (1)
Allergies (100)
Alliances (33156)
ALS (118)
Alzheimer's disease (994)
Antibody-drug conjugate (ADC) (319)
Approvals (10467)
Artificial intelligence (358)
ASCO (160)
Autoimmune disease (235)
Automation (33)
Bankruptcy (263)
Belgium (4)
Best Places to Work (6957)
BIO (36)
Biologics (33)
BIOSECURE Act (1)
Biosimilars (123)
BioSpace Insights (17)
Biotechnology (89)
Bispecific (14)
Bladder cancer (143)
Brain cancer (35)
Breast cancer (537)
Cancer (3955)
Cardiovascular disease (236)
Career advice (245)
Career pathing (1)
CAR-T (184)
CDC (1)
CDMO (28)
Celiac Disease (3)
Cell therapy (506)
Cervical cancer (36)
Clinical research (48379)
Collaboration (1355)
Commercialization (22)
Compensation (1607)
Complete response letters (36)
COVID-19 (769)
CRISPR (68)
C-suite (848)
Cystic fibrosis (89)
Data (6272)
Denatured (4)
Depression (108)
Dermatology (95)
Diabetes (377)
Diagnostics (4254)
Digital health (40)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (169)
Drug pricing (7)
Drug shortages (3)
Duchenne muscular dystrophy (174)
Earnings (73912)
Editorial (1)
Employer branding (2)
Employer resources (14)
ESMO (188)
Events (88654)
Executive appointments (734)
Eye disease (3)
FDA (12657)
Fibrodysplasia Ossificans Progressiva (11)
Fragile X (1)
Friedreich's ataxia (19)
Frontotemporal dementia (25)
Funding (992)
Gene editing (132)
Generative AI (13)
Gene therapy (350)
GLP-1 (309)
Government (949)
Grass and pollen (2)
Guidances (281)
Healthcare (9384)
Hematology (94)
HIV (56)
Huntington's disease (26)
Idiopathic pulmonary fibrosis (5)
IgA nephropathy (78)
Immunology and inflammation (113)
Immuno-oncology (68)
Indications (177)
Infectious disease (970)
Inflammatory bowel disease (141)
Inflation Reduction Act (4)
Influenza (87)
Intellectual property (270)
Interviews (41)
IPO (12397)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (19)
Kidney disease (77)
Layoffs (59)
Legal (5195)
Licensing (46)
Liver cancer (46)
Longevity (25)
Lung cancer (569)
Lung diease (8)
Lymphoma (266)
Machine learning (30)
Management (3)
Manufacturing (615)
Marketing (19)
MASH (121)
Medical affairs (2)
Medical device (8710)
Medtech (8889)
Mergers & acquisitions (14451)
Metabolic disorders (763)
mRNA (71)
Multiple sclerosis (115)
Multispecific (2)
NASH (4)
Netherlands (2)
Neurodegenerative disease (240)
Neuropsychiatric disorders (40)
Neuroscience (1931)
Neurotech (2)
NextGen: Class of 2026 (3150)
Non-profit (844)
Obesity (240)
Opinion (10)
Ovarian cancer (177)
Pain (189)
Pancreatic cancer (229)
Parkinson's disease (217)
Partnered (12)
Patents (522)
Patient advocacy (2)
Patient recruitment (548)
Patient selection (36)
Peanut (33)
People (41500)
Peptides (14)
Pharmaceutical (30)
Pharmacy benefit managers (10)
Phase 1 (15609)
Phase 2 (21615)
Phase 3 (14592)
Pipeline (8337)
Policy (18)
Postmarket research (1570)
Preclinical (6591)
Press Release (34)
Prostate cancer (203)
Psychedelics (10)
Radiopharmaceuticals (203)
Rare diseases (621)
Real estate (3024)
Recruiting (6)
Regenerative medicine (12)
Regulatory (15166)
Reports (23)
Research institute (590)
Resumes & cover letters (45)
Rett syndrome (46)
RNA editing (9)
RSV (49)
Schizophrenia (109)
Series A (173)
Series B (126)
Service/supplier (5)
Sickle cell disease (65)
Spinal muscular atrophy (92)
Sponsored (5)
Startups (2021)
Stem cells (1)
Stomach cancer (3)
Substance use disorders (16)
Supply chain (54)
Tariffs (1)
Vaccines (349)
Venture capital (17)
Weight loss (77)
Wet AMD (3)
Women's health (98)
Date
Today (31)
Last 7 days (390)
Last 30 days (1581)
Last 365 days (19142)
2026 (15421)
2025 (19251)
2024 (22987)
2023 (26538)
2022 (34586)
2021 (37167)
2020 (33468)
2019 (23256)
2018 (17468)
2017 (18766)
2016 (17917)
2015 (24263)
2014 (21679)
2013 (18135)
2012 (20221)
2011 (20440)
2010 (20332)
Location
Africa (231)
Alabama (80)
Alaska (2)
Arizona (319)
Arkansas (12)
Asia (18044)
Australia (2117)
California (12837)
Canada (3351)
China (570)
Colorado (526)
Connecticut (445)
Delaware (224)
Europe (24789)
Florida (1926)
Georgia (405)
Hawaii (3)
Idaho (46)
Illinois (765)
India (59)
Indiana (331)
Iowa (18)
Japan (452)
Kansas (104)
Kentucky (33)
Louisiana (28)
Maine (27)
Maryland (1272)
Massachusetts (8397)
Michigan (321)
Minnesota (593)
Mississippi (4)
Missouri (84)
Montana (20)
Nebraska (11)
Nevada (132)
New Hampshire (60)
New Jersey (2824)
New Mexico (12)
New York (3005)
North Carolina (1362)
North Dakota (4)
Northern California (6503)
Ohio (304)
Oklahoma (15)
Oregon (17)
Pennsylvania (2388)
Puerto Rico (24)
Rhode Island (31)
South America (407)
South Carolina (81)
South Dakota (1)
Southern California (5345)
Tennessee (128)
Texas (2117)
United States (41590)
Utah (391)
Vermont (1)
Virginia (166)
Washington D.C. (39)
Washington State (985)
West Virginia (1)
Wisconsin (81)
Wyoming (1)
487,784 Results for "avivagen inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Avivagen Inc. Announces Results for the Second Quarter Ending April 30, 2023
Avivagen Inc. has announced its unaudited financial results for the Second quarter of 2023.
June 6, 2023
·
6 min read
Avivagen Provides Corporate Updates - July 31, 2023
Avivagen Inc. announces several corporate updates, relating to the allowances of patents, a waiver of an interest payment on its senior secured debentures and the continuation of the strategic review process.
July 31, 2023
·
6 min read
Avivagen Announces Significant Increase in Sales to an Existing Customer
Avivagen Inc. is pleased to announce that an existing customer has placed an order sized at 400% of its normal monthly order volume.
May 25, 2023
·
4 min read
Business
Avivagen Inc. Announces Results for the Third Quarter Ending July 31, 2022
Avivagen Inc. has announced its unaudited financial results for the third quarter of 2022.
September 16, 2022
·
5 min read
Business
Avivagen Inc. Announces Results for the First Quarter Ending January 31, 2023
Avivagen Inc., a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance, has announced its unaudited financial results for the first quarter of 2023.
March 16, 2023
·
5 min read
Avivagen Inc. Provides Update on Securities for Service Agreements With CEO and CSO
Avivagen Inc. announces that pursuant to its previously announced “Securities for Services” agreements with Top Meadow Consulting Services Inc. and Mr. Graham Burton, the Company has issued an aggregate of 507,345 common shares in the capital of the Company to Top Meadow Consulting Services Inc. and Mr. Graham Burton.
March 28, 2023
·
4 min read
Avivagen Announces New Orders for 1.1 Tonnes of Oxc-Beta™ Livestock Product
Avivagen Inc., a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance, is pleased to announce two orders for OxC-beta™.
July 24, 2023
·
4 min read
Business
Avivagen Reports Fiscal Year 2022 Financial Results and Strategic Initiatives to Accelerate Growth
Avivagen Inc. today reported its audited financial results for the year ended October 31, 2022 and the implementation of a strategic plan to accelerate growth.
February 21, 2023
·
7 min read
Business
Avivagen Announces CEO Update to Shareholders
Avivagen Inc announces a CEO update to shareholders.
January 26, 2022
·
11 min read
Business
Avivagen Announces Appointment of James Nickerson as President
Avivagen Inc. is excited to announce the appointment of James (“Jamie”) Nickerson, PhD as President of Avivagen.
January 25, 2022
·
5 min read
1 of 48,779
Next
